Abstract
Various useful animal models, such as Alzheimer’s disease and Niemann–Pick disease, were provided by U18666A. However, the pathogenesis of U18666A-induced diseases, including U18666A-mediated apoptosis, remains incompletely elucidated, and therapeutic strategies are still limited. Dihydrotestosterone (DHT) has been reported to contribute to the prevention and treatment of neurodegenerative disorders. Our study investigated the neuroprotective activity of DHT in U18666A-related diseases. Apoptosis of C6 cells was detected by Hoechst 33258 fluorescent staining and flow cytometry with annexin V-FITC/PI dual staining. Cell viability was assessed using Cell Counting Kit-8. Expression of apoptosis-related proteins, such as Akt, seladin-1, Bcl-2 family proteins, and caspase-3, was determined using Western blot. Our results demonstrated that the apoptotic rate of C6 cells significantly increased after U18666A addition, but was remarkably reduced after DHT treatment. Pretreatment with DHT attenuated U18666A-induced cell viability loss. PI3K inhibitor LY294002 could suppress DHT anti-apoptotic effect. Furthermore, we discovered that U18666A could significantly downregulate seladin-1 expression in a dose-dependent manner, but no significant change was observed in Bcl-xL, Bax, and P-Akt protein expressions. Compared with U18666A-treated group, the expression of P-Akt, seladin-1, and Bcl-xL significantly increased, and the expression of Bax and caspase-3 remarkably reduced after DHT treatment. However, in the presence of LY294002, the effect of DHT was reversed. In conclusion, we found that seladin-1 may take part in U18666A-induced apoptosis. DHT may inhibit U18666A-induced apoptosis by regulating downstream apoptosis-related proteins including seladin-1, caspase-3, Bcl-xL, and Bax through activation of the PI3K/Akt signal pathway.
Similar content being viewed by others
References
Akishita M (2013) Role of androgen in the elderly. Dementia and androgen. Clin Calcium 23:1151–1155
Bachoo RM, Kim RS, Ligon KL, Maher EA, Brennan C, Billings N, Chan S, Li C, Rowitch DH, Wong WH, DePinho RA (2004) Molecular diversity of astrocytes with implications for neurological disorders. Proc Natl Acad Sci USA 101:8384–8389
Battista MC, Roberge C, Martinez A, Gallo-Payet N (2009) 24-dehydrocholesterol reductase/seladin-1: a key protein differentially involved in adrenocorticotropin effects observed in human and rat adrenal cortex. Endocrinology 150:4180–4190
Battista MC, Guimond MO, Roberge C, Doueik AA, Fazli L, Gleave M, Sabbagh R, Gallo-Payet N (2010) Inhibition of DHCR24/seladin-1 impairs cellular homeostasis in prostate cancer. Prostate 70:921–933
Bing L, Wu J, Zhang J, Chen Y, Hong Z, Zu H (2015) DHT inhibits the abeta25-35-induced apoptosis by regulation of seladin-1, survivin, XIAP, bax, and bcl-xl expression through a rapid PI3-K/Akt signaling in C6 glial cell lines. Neurochem Res 40:41–48
Biondi E (2011) Prescription of lipophilic statins to Alzheimer’s disease patients: some controversies to consider. Neurol Sci 32:195–201
Cenedella RJ (2009) Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes. Lipids 44:477–487
Cenedella RJ, Sexton PS, Krishnan K, Covey DF (2005) Comparison of effects of U18666A and enantiomeric U18666A on sterol synthesis and induction of apoptosis. Lipids 40:635–640
Cheung NS, Koh CH, Bay BH, Qi RZ, Choy MS, Li QT, Wong KP, Whiteman M (2004) Chronic exposure to U18666A induces apoptosis in cultured murine cortical neurons. Biochem Biophys Res Commun 315:408–417
Dias C, Rupps R, Millar B, Choi K, Marra M, Demos M, Kratz LE, Boerkoel CF (2014) Desmosterolosis: an illustration of diagnostic ambiguity of cholesterol synthesis disorders. Orphanet J Rare Dis 9:94
Dong F, Mo Z, Eid W, Courtney KC, Zha X (2014) Akt inhibition promotes ABCA1-mediated cholesterol efflux to ApoA-I through suppressing mTORC1. PLoS One 9:e113789
Fletcher R, Gribben C, Ma X, Burchfield JG, Thomas KC, Krycer JR, James DE, Fazakerley DJ (2014) The role of the Niemann-Pick disease, type C1 protein in adipocyte insulin action. PLoS One 9:e95598
Gatson JW, Kaur P, Singh M (2006) Dihydrotestosterone differentially modulates the mitogen-activated protein kinase and the phosphoinositide 3-kinase/Akt pathways through the nuclear and novel membrane androgen receptor in C6 cells. Endocrinology 147:2028–2034
Greeve I, Hermans-Borgmeyer I, Brellinger C, Kasper D, Gomez-Isla T, Behl C, Levkau B, Nitsch RM (2000) The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer’s disease-associated neurodegeneration and oxidative stress. J Neurosci 20:7345–7352
Hagiwara K, Nakamura Y, Nishijima M, Yamakawa Y (2007) Prevention of prion propagation by dehydrocholesterol reductase inhibitors in cultured cells and a therapeutic trial in mice. Biol Pharm Bull 30:835–838
Hamdi MM, Mutungi G (2011) Dihydrotestosterone stimulates amino acid uptake and the expression of LAT2 in mouse skeletal muscle fibres through an ERK1/2-dependent mechanism. J Physiol 589:3623–3640
Heneka MT, Carson MJ, El KJ, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP (2015) Neuroinflammation in Alzheimer’s disease. Lancet Neurol 14:388–405
Hwang SL, Lin JA, Shih PH, Yeh CT, Yen GC (2012) Pro-cellular survival and neuroprotection of citrus flavonoid: the actions of hesperetin in PC12 cells. Food Funct 3:1082–1090
Kang L, Li S, Xing Z, Li J, Su Y, Fan P, Wang L, Cui H (2014) Dihydrotestosterone treatment delays the conversion from mild cognitive impairment to Alzheimer’s disease in SAMP8 mice. Horm Behav 65:505–515
Kline LW, Karpinski E (2008) Testosterone and dihydrotestosterone inhibit gallbladder motility through multiple signalling pathways. Steroids 73:1174–1180
Koh CH, Cheung NS (2006) Cellular mechanism of U18666A-mediated apoptosis in cultured murine cortical neurons: bridging Niemann-Pick disease type C and Alzheimer’s disease. Cell Signal 18:1844–1853
Koh CH, Qi RZ, Qu D, Melendez A, Manikandan J, Bay BH, Duan W, Cheung NS (2006) U18666A-mediated apoptosis in cultured murine cortical neurons: role of caspases, calpains and kinases. Cell Signal 18:1572–1583
Kudo W, Lee HP, Smith MA, Zhu X, Matsuyama S, Lee HG (2012) Inhibition of Bax protects neuronal cells from oligomeric Abeta neurotoxicity. Cell Death Dis 3:e309
Lee MK, Smith SM, Murray S, Pham LD, Minoo P, Nielsen HC (2014) Dihydrotestosterone potentiates EGF-induced ERK activation by inducing SRC in fetal lung fibroblasts. Am J Respir Cell Mol Biol 51:114–124
Liu R, Ding L, Yu MH, Wang HQ, Li WC, Cao Z, Zhang P, Yao BC, Tang J, Ke Q, Huang TZ (2014) Effects of dihydrotestosterone on adhesion and proliferation via PI3-K/Akt signaling in endothelial progenitor cells. Endocrine 46:634–643
Nuti F, Luciani P, Marinari E, Erdei E, Bak M, Deledda C, Rosati F, Mazzinghi B, Danza G, Stoop H, Looijenga LH, Peri A, Serio M, Krausz C (2009) Seladin-1 and testicular germ cell tumours: new insights into cisplatin responsiveness. J Pathol 219:491–500
Peri A, Serio M (2008a) Neuroprotective effects of the Alzheimer’s disease-related gene seladin-1. J Mol Endocrinol 41:251–261
Peri A, Serio M (2008b) Estrogen receptor-mediated neuroprotection: the role of the Alzheimer’s disease-related gene seladin-1. Neuropsychiatr Dis Treat 4:817–824
Qu M, Shen W (2015) Role of PI3K/Akt pathway in endoplasmic reticulum stress and apoptosis induced by saturated fatty acid in human steatotic hepatocytes. Zhonghua Gan Zang Bing Za Zhi 23:194–199
Ramos MC, Sierra S, Ramirez C, Velasco J, Burgos JS (2012) Simvastatin modulates the Alzheimer’s disease-related gene seladin-1. J Alzheimers Dis 28:297–301
Sarajarvi T, Haapasalo A, Viswanathan J, Makinen P, Laitinen M, Soininen H, Hiltunen M (2009) Down-regulation of seladin-1 increases BACE1 levels and activity through enhanced GGA3 depletion during apoptosis. J Biol Chem 284:34433–34443
Shang YC, Chong ZZ, Wang S, Maiese K (2012) Prevention of beta-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL. Aging (Albany NY) 4:187–201
Sun YH, Xu CQ, Li H, Shi S, Zhang WH, Zhao YJ, Zhang YQ, Han WM, Han LP, Jiang CM, Li QF, Wang R (2006) Association between calcium-sensing receptor protein expression and rat cardiomyocyte apoptosis. Zhonghua Xin Xue Guan Bing Za Zhi 34:739–743
Tokunaga E, Oki E, Egashira A, Sadanaga N, Morita M, Kakeji Y, Maehara Y (2008) Deregulation of the Akt pathway in human cancer. Curr Cancer Drug Targets 8:27–36
Wang Y, Rogers PM, Stayrook KR, Su C, Varga G, Shen Q, Nagpal S, Burris TP (2008) The selective Alzheimer’s disease indicator-1 gene (Seladin-1/DHCR24) is a liver X receptor target gene. Mol Pharmacol 74:1716–1721
Whayne TJ (2013) Problems and possible solutions for therapy with statins. Int J Angiol 22:75–82
Xia Y, Wang CZ, Liu J, Anastasio NC, Johnson KM (2010) Brain-derived neurotrophic factor prevents phencyclidine-induced apoptosis in developing brain by parallel activation of both the ERK and PI-3 K/Akt pathways. Neuropharmacology 58:330–336
Yea SS, Fruman DA (2013) Achieving cancer cell death with PI3K/mTOR-targeted therapies. Ann N Y Acad Sci 1280:15–18
Yoo YE, Ko CP (2012) Dihydrotestosterone ameliorates degeneration in muscle, axons and motoneurons and improves motor function in amyotrophic lateral sclerosis model mice. PLoS One 7:e37258
Zerenturk EJ, Sharpe LJ, Ikonen E, Brown AJ (2013) Desmosterol and DHCR24: unexpected new directions for a terminal step in cholesterol synthesis. Prog Lipid Res 52:666–680
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yao, K., Wu, J., Zhang, J. et al. Protective Effect of DHT on Apoptosis Induced by U18666A via PI3K/Akt Signaling Pathway in C6 Glial Cell Lines. Cell Mol Neurobiol 36, 801–809 (2016). https://doi.org/10.1007/s10571-015-0263-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-015-0263-x